Senior executive with 25+ years spanning the life sciences, clinical diagnostic, medical device and venture capital arenas building strategic and commercial value around disruptive technologies. Chris is an experienced leader with demonstrated success in corporate and strategic development, mergers & acquisitions and asset monetization across pre-revenue/development stage environments to growth phase organizations. With a strong operational foundation leading multinational supply chain and manufacturing organizations and corporate development initiatives, he is highly successful in building relationships with executive decision makers, seizing control of critical corporate challenges and delivering on customer commitments. Chris is performance driven to leverage strategic assets, intellectual property and commercial portfolios, increasing shareholder value and accelerating growth.